Telix Pharmaceuticals Statistics
Total Valuation
TLX has a market cap or net worth of $4.05 billion. The enterprise value is $3.98 billion.
| Market Cap | 4.05B |
| Enterprise Value | 3.98B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TLX has 341.06 million shares outstanding.
| Shares Outstanding | 341.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 190.42.
| PE Ratio | 190.42 |
| Forward PE | n/a |
| PS Ratio | 10.47 |
| Forward PS | n/a |
| PB Ratio | 33.44 |
| P/FCF Ratio | 559.43 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 187.17 |
| EV / Sales | 10.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 549.86 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.76 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 17.48% and return on invested capital (ROIC) is 24.94%.
| Return on Equity (ROE) | 17.48% |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 24.94% |
| Revenue Per Employee | $931,948 |
| Profits Per Employee | $51,228 |
| Employee Count | 415 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLX had revenue of $386.76 million and earned $21.26 million in profits. Earnings per share was $0.06.
| Revenue | 386.76M |
| Gross Profit | 245.19M |
| Operating Income | 33.37M |
| Pretax Income | 21.17M |
| Net Income | 21.26M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $0.06 |
Balance Sheet
The company has $81.99 million in cash and $12.75 million in debt, giving a net cash position of $69.24 million or $0.20 per share.
| Cash & Cash Equivalents | 81.99M |
| Total Debt | 12.75M |
| Net Cash | 69.24M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 121.06M |
| Book Value Per Share | 0.35 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was $17.98 million and capital expenditures -$10.74 million, giving a free cash flow of $7.24 million.
| Operating Cash Flow | 17.98M |
| Capital Expenditures | -10.74M |
| Free Cash Flow | 7.24M |
| FCF Per Share | $0.02 |
Margins
Gross margin is 63.40%, with operating and profit margins of 8.63% and 5.50%.
| Gross Margin | 63.40% |
| Operating Margin | 8.63% |
| Pretax Margin | 5.47% |
| Profit Margin | 5.50% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 1.87% |
Dividends & Yields
TLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.53% |
| FCF Yield | 0.18% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |